인공호흡 및 마취용 마스크 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 용도별, 지역별 및 부문별 예측(2026-2033년)

Artificial Ventilation And Anesthesia Market Summary

The global artificial ventilation and anesthesia masks market size was valued at USD 1.6 billion in 2025 and is projected to grow from USD 1.7 billion in 2026 to USD 2.6 billion by 2033, at a CAGR of 6.0% from 2026 to 2033. North America dominated the market with a revenue share of 37.9% in 2025. The market is primarily driven by the rising incidence of respiratory diseases, ongoing technological advancements in respiratory care devices, increasing number of surgical procedures, and the growing geriatric population, which is more susceptible to chronic respiratory conditions.

Global Artificial Ventilation and Anesthesia Masks Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global artificial ventilation and anesthesia masks market report based on product type, application, and region:

• Product Type Outlook (Volume, 000' Units; Revenue, USD Billion, 2021 - 2033)
• Artificial Ventilation Masks
  • Disposable
  • Full-Face Mask
  • Nasal Mask
  • Total-Face Mask
  • Helmets
  • Reusable
  • Full-Face Mask
  • Nasal Mask
  • Total-Face Mask
  • Helmets
• Anesthesia Masks
  • Disposable
  • Reusable
• Application Outlook (Volume, 000' Units; Revenue, USD Billion, 2021 - 2033)
• Operating Rooms
• ICU
• Emergency Rooms
• HomeCare
• ASC
• Regional Outlook (Volume, 000' Units; Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type Segment
  • 1.1.2. Application Segment
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information or Data Analysis
  • 1.3.1. Data analysis models
• 1.4. Market Formulation & Validation
• 1.5. Model Details
  • 1.5.1. Commodity flow analysis (Model 1)
    • 1.5.1.1. Approach 1: Commodity flow approach
  • 1.5.2. Volume price analysis (Model 2)
    • 1.5.2.1. Approach 2: Volume price analysis
• 1.6. List of Secondary Sources
• 1.7. List of Primary Sources
• 1.8. Objectives
  • 1.8.1. Objective 1
  • 1.8.2. Objective 2
  • 1.8.3. Objective 3

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type Outlook
  • 2.2.2. Application Outlook
  • 2.2.3. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Artificial Ventilation and Anesthesia Masks Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Industry Value Chain Analysis
  • 3.2.1. Reimbursement framework
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Increasing number of surgical procedures globally
    • 3.3.1.2. Rising prevalence of chronic respiratory diseases
    • 3.3.1.3. Growing technological advancements in anesthesia and artificial ventilation masks
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Patient discomfort and skin injuries associated with prolonged mask usage
    • 3.3.2.2. Limitations associated with conventional anesthesia mask designs
  • 3.3.3. Market Opportunity Analysis
    • 3.3.3.1. Growing adoption of non-invasive ventilation and critical care respiratory support
    • 3.3.3.2. Rising demand for disposable and infection-control-focused masks
    • 3.3.3.3. Emerging potential of 3d printing for customized respiratory mask design
  • 3.3.4. Industry Challenge
• 3.4. Anesthesia Masks Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Social landscape
    • 3.4.2.4. Economic landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Artificial Ventilation and Anesthesia Masks Market: Product Type Estimates & Trend Analysis

• 4.1. Product Type Market Share, 2025 & 2033
• 4.2. Segment Dashboard
• 4.3. Global Artificial Ventilation and Anesthesia Masks Market by Product Type Outlook
• 4.4. Artificial Ventilation Masks
  • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)
  • 4.4.2. Disposable
    • 4.4.2.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)
    • 4.4.2.2. Full-Face Mask
      • 4.4.2.2.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)
    • 4.4.2.3. Nasal Mask
      • 4.4.2.3.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)
    • 4.4.2.4. Total-Face Mask
      • 4.4.2.4.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)
    • 4.4.2.5. Helmets
      • 4.4.2.5.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)
  • 4.4.3. Reusable
    • 4.4.3.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)
    • 4.4.3.2. Full-Face Mask
      • 4.4.3.2.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)
    • 4.4.3.3. Nasal Mask
      • 4.4.3.3.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)
    • 4.4.3.4. Total-Face Mask
      • 4.4.3.4.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)
    • 4.4.3.5. Helmets
      • 4.4.3.5.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)
• 4.5. Anesthesia Masks
  • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)
  • 4.5.2. Disposable
    • 4.5.2.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)
  • 4.5.3. Reusable
    • 4.5.3.1. Market estimates and forecast 2021 to 2033 (USD Million) (000' Units)

Chapter 5. Artificial Ventilation and Anesthesia Masks Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2025 & 2033
• 5.2. Segment Dashboard
• 5.3. Global Artificial Ventilation and Anesthesia Masks Market by Application Outlook
  • 5.3.1. Operating Rooms
    • 5.3.1.1. Market estimates and forecast 2021 to 2033, (USD Million) (000' Units)
  • 5.3.2. ICU
    • 5.3.2.1. Market estimates and forecast 2021 to 2033, (USD Million)
  • 5.3.3. Emergency Rooms
    • 5.3.3.1. Market estimates and forecast 2021 to 2033, (USD Million) (000' Units)
  • 5.3.4. HomeCare
    • 5.3.4.1. Market estimates and forecast 2021 to 2033, (USD Million) (000' Units)
  • 5.3.5. ASC
    • 5.3.5.1. Market estimates and forecast 2021 to 2033, (USD Million) (000' Units)

Chapter 6. Artificial Ventilation and Anesthesia Masks Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. Market Size, Forecasts, & Trends Analysis, 2021 to 2033:
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.5.3. Mexico
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.6.6. Sweden
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.6.7. Denmark
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.6.8. Norway
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.7.4. South Korea
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.7.5. Thailand
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.7.6. Australia
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.8.2. Argentina
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Regulatory framework
    • 6.9.1.3. Competitive scenario
    • 6.9.1.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. Market estimates and forecast, 2021 - 2033 (USD Million) (000' Units)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key Company Market Position Analysis, 2025
• 7.4. Global Company Market Share Analysis, 2025 (%)
  • 7.4.1. Company Market Share Analysis, by region 2025 (%)
  • 7.4.2. Company Market Revenue Analysis, 2025 (USD Million)
  • 7.4.3. Company Market Volume Analysis, 2025 (000' Units)
• 7.5. Company ASP, Volume & Regional Trend Positioning (2025)
• 7.6. Unit Price/ASP by Company and by Region for Artificial Ventilation Mask, 2025
• 7.7. Unit Price/ASP by Company and by Region for Anesthesia Masks, 2025
• 7.8. Company Profiles
  • 7.8.1. Koninklijke Philips N.V.
    • 7.8.1.1. Company overview
    • 7.8.1.2. Financial performance
    • 7.8.1.3. Product benchmarking
    • 7.8.1.4. Strategic initiatives
  • 7.8.2. Nihon Kohden Corporation
    • 7.8.2.1. Company overview
    • 7.8.2.2. Financial performance
    • 7.8.2.3. Product benchmarking
    • 7.8.2.4. Strategic initiatives
  • 7.8.3. Cardinal Health
    • 7.8.3.1. Company overview
    • 7.8.3.2. Financial performance
    • 7.8.3.3. Product benchmarking
    • 7.8.3.4. Strategic initiatives
  • 7.8.4. Medtronic
    • 7.8.4.1. Company overview
    • 7.8.4.2. Financial performance
    • 7.8.4.3. Product benchmarking
    • 7.8.4.4. Strategic initiatives
  • 7.8.5. Ambu A/S
    • 7.8.5.1. Company overview
    • 7.8.5.2. Financial performance
    • 7.8.5.3. Product benchmarking
    • 7.8.5.4. Strategic initiatives
  • 7.8.6. Dragerwerk AG & Co. KGaA
    • 7.8.6.1. Company overview
    • 7.8.6.2. Financial performance
    • 7.8.6.3. Product benchmarking
    • 7.8.6.4. Strategic initiatives
  • 7.8.7. Fisher & Paykel Healthcare Limited
    • 7.8.7.1. Company overview
    • 7.8.7.2. Financial performance
    • 7.8.7.3. Product benchmarking
    • 7.8.7.4. Strategic initiatives
  • 7.8.8. ResMed Inc.
    • 7.8.8.1. Company overview
    • 7.8.8.2. Financial performance
    • 7.8.8.3. Product benchmarking
    • 7.8.8.4. Strategic initiatives
  • 7.8.9. HMC Premedical S.p.A
    • 7.8.9.1. Company overview
    • 7.8.9.2. Financial performance
    • 7.8.9.3. Product benchmarking
    • 7.8.9.4. Strategic initiatives
  • 7.8.10. Intersurgical Ltd
    • 7.8.10.1. Company overview
    • 7.8.10.2. Financial performance
    • 7.8.10.3. Product benchmarking
    • 7.8.10.4. Strategic initiatives
  • 7.8.11. Hamilton Medical
    • 7.8.11.1. Company overview
    • 7.8.11.2. Financial performance
    • 7.8.11.3. Product benchmarking
    • 7.8.11.4. Strategic initiatives
  • 7.8.12. Air Liquide Medical Systems
    • 7.8.12.1. Company overview
    • 7.8.12.2. Financial performance
    • 7.8.12.3. Product benchmarking
    • 7.8.12.4. Strategic initiatives